Crispr Therapeutics shares owned by South Street Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by South Street Advisors
from 13F filings
Historical chart of South Street Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by South Street Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by South Street Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $208k | 3.2k | 64.81 |